91 related articles for article (PubMed ID: 9851127)
1. [Follicular lymphoma, medium-sized cell type and mixed type].
Ohno T; Ito M; Shiku H
Ryoikibetsu Shokogun Shirizu; 1998; (22 Pt 3):235-9. PubMed ID: 9851127
[No Abstract] [Full Text] [Related]
2. Value of autologous stem cell transplantation with purged bone marrow as first-line therapy for follicular lymphoma with high tumor burden: a GOELAMS phase II study.
Colombat P; Cornillet P; Deconinck E; Tourani JM; Gardembas M; Delain M; Abgrall JF; Kootz C; Milpied N
Bone Marrow Transplant; 2000 Nov; 26(9):971-7. PubMed ID: 11100276
[TBL] [Abstract][Full Text] [Related]
3. Occult lymphoma cells prevalent in autologous marrow from non-Hodgkin's diffuse lymphoma.
Yokoyama J; Fujimiya Y; Yamaguchi T; Shiga K; Saijo Y; Groveman DS; McBain JA; Suzuki Y; Ebina T
Am J Hematol; 2003 May; 73(1):1-11. PubMed ID: 12701113
[TBL] [Abstract][Full Text] [Related]
4. [Follicular lymphomas].
García-Conde J; Tormo M; Terol MJ; Benet I
Sangre (Barc); 1997 Jun; 42(3):243-5. PubMed ID: 9381271
[No Abstract] [Full Text] [Related]
5. [Follicular lymphoma].
Illés A; Krenács L; Borbényi Z
Orv Hetil; 2003 Nov; 144(46):2253-61. PubMed ID: 14702920
[TBL] [Abstract][Full Text] [Related]
6. [Achieving Bcl-2/IgH negativity in peripheral blood/bone marrow after therapy implies better prognosis for patients with follicular lymphoma].
Belada D; Smolej L; Stepánková P; Beránek M; Dvoráková D; Bukac J; Malý J
Vnitr Lek; 2007 Oct; 53(10):1057-63. PubMed ID: 18072430
[TBL] [Abstract][Full Text] [Related]
7. Transformation of follicular lymphoma to Burkitt-like lymphoma within a single lymph node.
Mukhopadhyay S; Readling J; Cotter PD; Shrimpton AE; Sidhu JS
Hum Pathol; 2005 May; 36(5):571-5. PubMed ID: 15948125
[TBL] [Abstract][Full Text] [Related]
8. Molecular diagnostics in follicular non-Hodgkin's lymphoma: a review.
Bordeleau L; Berinstein NL
Semin Oncol; 2000 Dec; 27(6 Suppl 12):42-52. PubMed ID: 11226000
[TBL] [Abstract][Full Text] [Related]
9. High-dose therapy combined with peripheral blood stem cell transplantation for advanced low-grade follicular lymphoma: single-institution experience in Japan.
Fujimori Y; Saheki K; Yamada S; Yamada S; Mori A; Itoh T; Okada M; Takatsuka H; Wada H; Tamura S; Okamoto T; Takemoto Y; Kakishita E; Nagai K
Int J Hematol; 1999 Oct; 70(3):207-8. PubMed ID: 10561916
[No Abstract] [Full Text] [Related]
10. The role of hematopoietic stem cell transplantation in non-Hodgkin lymphoma.
Villanueva ML; Vose JM
Clin Adv Hematol Oncol; 2006 Jul; 4(7):521-30. PubMed ID: 17147239
[TBL] [Abstract][Full Text] [Related]
11. Detection and quantification of MBR/JH2 t(14;18) BCL-2 gene rearrangement in follicular lymphoma using a combined real-time polymerase chain reaction assay.
Csernák E; Tóth E; Melegh Z; Schneider T; Rosta A; Szentirmay Z
Haematologica; 2006 Jun; 91(6):858-9. PubMed ID: 16704964
[TBL] [Abstract][Full Text] [Related]
12. Do cytogenetic abnormalities precede morphologic abnormalities in a developing malignant condition?
Northup JK; Gadre SA; Ge Y; Lockhart LH; Velagaleti GV
Eur J Haematol; 2007 Feb; 78(2):152-6. PubMed ID: 17313561
[TBL] [Abstract][Full Text] [Related]
13. [Clinical and molecular pathogenesis of follicular lymphoma].
Karube K
Rinsho Ketsueki; 2008 Mar; 49(3):159-64. PubMed ID: 18421956
[No Abstract] [Full Text] [Related]
14. LightCycler-based quantitative real-time PCR monitoring of patients with follicular lymphoma receiving rituximab in combination with conventional or high-dose cytotoxic chemotherapy.
Martin S; Fischer C; Free M; Kurreck B; Stockinger H; Fenk R; Arnold C; Kliszewski S; Meckenstock G; Haas R; Kronenwett R
Eur J Haematol; 2005 Apr; 74(4):282-92. PubMed ID: 15777339
[TBL] [Abstract][Full Text] [Related]
15. [Current clinical aspects of follicular lymphoma].
Dreyling M
Ther Umsch; 2010 Oct; 67(10):511-6. PubMed ID: 20886457
[TBL] [Abstract][Full Text] [Related]
16. bcl-2 evaluation in patients in long-term complete remission after bone marrow transplantation.
Colombat P; Garrigue MA; Lamagnere JP; Muh JP; Linassier C
J Clin Oncol; 1994 Nov; 12(11):2516. PubMed ID: 7964969
[No Abstract] [Full Text] [Related]
17. Infused CD34 cell dose, but not tumour cell content of peripheral blood progenitor cell grafts, predicts clinical outcome in patients with diffuse large B-cell lymphoma and follicular lymphoma grade 3 treated with high-dose therapy.
Blystad AK; Delabie J; Kvaløy S; Holte H; Vålerhaugen H; Ikonomou I; Kvalheim G
Br J Haematol; 2004 Jun; 125(5):605-12. PubMed ID: 15147376
[TBL] [Abstract][Full Text] [Related]
18. Third biannual report of the Cochrane Haematological Malignancies Group.
Kober T; Skoetz N; Trelle S; Bohlius J; Engert A;
J Natl Cancer Inst; 2005 Aug; 97(16):E2. PubMed ID: 16106014
[No Abstract] [Full Text] [Related]
19. Biclonal follicular lymphoma: histological, clinical and molecular characteristics.
Noriega MF; De Brasi C; Narbaitz M; Rodríguez A; Slavutsky I
Pathology; 2010; 42(6):598-601. PubMed ID: 20854087
[No Abstract] [Full Text] [Related]
20. A case of primary follicular lymphoma of the duodenum with BCL-2 gene rearrangement.
Matsuzawa M; Shimodaira K; Nakamura N; Ochi Y; Hosaka S; Kiyosawa K; Matsuzawa M; Akamatsu T; Sugiyama A; Ota H; Katsuyama T
J Gastroenterol; 2003; 38(5):512-3. PubMed ID: 12768397
[No Abstract] [Full Text] [Related]
[Next] [New Search]
